Missing trials from regulatory document of methylphenidate for adults with attention-deficit/hyperactivity disorder: Response to Boesen et al
J Clin Epidemiol
.
2022 May:145:185-186.
doi: 10.1016/j.jclinepi.2021.12.020.
Epub 2021 Dec 16.
Author
Rafał R Jaeschke
1
Affiliation
1
Section of Affective Disorders, Department of Psychiatry, Jagiellonian University Medical College, Krakow, Poland. Electronic address: rafal.jaeschke@gmail.com.
PMID:
34923025
DOI:
10.1016/j.jclinepi.2021.12.020
No abstract available
Publication types
Letter
Comment
MeSH terms
Adult
Attention Deficit Disorder with Hyperactivity* / drug therapy
Humans
Methylphenidate* / therapeutic use
Psychiatric Status Rating Scales
Substances
Methylphenidate